Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-06 Sale |
2021-08-10 4:52 pm |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
41,000 | $18.47 | $757,194 | 849,018 (Direct) |
View |
| 2021-07-21 Sale |
2021-07-23 4:06 pm |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
1,935 | $20.04 | $38,777 | 40,839 (Direct) |
View |
| 2021-06-04 Sale |
2021-06-08 4:25 pm |
Axogen Inc. | AXGN | MARTINEZ MARIA D. Chief Human Resources Officer |
2,652 | $18.86 | $50,017 | 2,932 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-12-27 Tax Withholding |
2021-12-29 4:17 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
187 | $9.74 | 87,999 (Direct) |
View |
| 2021-12-27 Exercise |
2021-12-29 4:17 pm |
2022-12-27 2022-12-27 |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
750 | $0 | 87,999 (Direct) |
View |
| 2021-12-27 Tax Withholding |
2021-12-29 4:15 pm |
N/A N/A |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
326 | $9.74 | 15,334 (Direct) |
View |
| 2021-12-27 Exercise |
2021-12-29 4:15 pm |
2022-12-27 2022-12-27 |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
1,150 | $0 | 15,334 (Direct) |
View |
| 2021-12-20 Tax Withholding |
2021-12-22 4:09 pm |
N/A N/A |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
1,243 | $9.24 | 923,029 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 4:09 pm |
N/A N/A |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
3,125 | $0 | 923,029 (Direct) |
View |
| 2021-12-20 Tax Withholding |
2021-12-22 4:07 pm |
N/A N/A |
Axogen Inc. | AXGN | MARIANI PETER J EVP & Chief Financial Officer |
757 | $9.24 | 22,169 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 4:07 pm |
N/A N/A |
Axogen Inc. | AXGN | MARIANI PETER J EVP & Chief Financial Officer |
1,900 | $0 | 22,169 (Direct) |
View |
| 2021-12-20 Tax Withholding |
2021-12-22 4:06 pm |
N/A N/A |
Axogen Inc. | AXGN | Friedman Mark Louis VP Regulatory Affairs & Policy |
95 | $9.24 | 16,588 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 4:06 pm |
2021-12-20 2021-12-20 |
Axogen Inc. | AXGN | Friedman Mark Louis VP Regulatory Affairs & Policy |
375 | $0 | 16,588 (Direct) |
View |
| 2021-12-20 Tax Withholding |
2021-12-22 4:04 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
95 | $9.24 | 41,119 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 4:04 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
375 | $0 | 41,119 (Direct) |
View |
| 2021-12-20 Tax Withholding |
2021-12-22 4:03 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
144 | $9.24 | 86,686 (Direct) |
View |
| 2021-12-20 Exercise |
2021-12-22 4:03 pm |
2021-12-20 2021-12-20 |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
575 | $0 | 86,686 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 4:02 pm |
2018-12-29 2021-12-29 |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
10,000 | $0 | 86,255 (Direct) |
View |
| 2021-12-15 Exercise |
2021-12-17 4:02 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
10,000 | $3.67 | 86,255 (Direct) |
View |
| 2021-12-15 Tax Withholding |
2021-12-17 4:02 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
4,171 | $8.8 | 86,255 (Direct) |
View |
| 2021-11-24 Exercise |
2021-11-29 4:09 pm |
2020-12-29 2026-12-29 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
52,375 | $8.95 | 1,078,272 (Direct) |
View |
| 2021-08-12 Exercise |
2021-08-16 4:10 pm |
2016-12-28 2022-12-28 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
8,254 | $5.09 | 895,518 (Direct) |
View |
| 2021-08-13 Exercise |
2021-08-16 4:10 pm |
2015-12-29 2021-12-29 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
46,500 | $3.67 | 895,518 (Direct) |
View |
| 2021-08-10 Exercise |
2021-08-10 4:52 pm |
N/A 2022-12-29 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
75,000 | $5.09 | 849,018 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:16 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
392 | $19.2 | 80,426 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:16 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP Peripheral Nerve Science |
1,580 | $0 | 80,426 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:15 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
637 | $19.2 | 42,774 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:15 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
2,572 | $0 | 42,774 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:15 pm |
N/A N/A |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
8,812 | $19.2 | 780,018 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:15 pm |
N/A N/A |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
22,077 | $0 | 780,018 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:14 pm |
N/A N/A |
Axogen Inc. | AXGN | Sandberg Eric Chief Commercial Officer |
1,090 | $19.2 | 6,541 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:14 pm |
N/A N/A |
Axogen Inc. | AXGN | Sandberg Eric Chief Commercial Officer |
4,408 | $0 | 6,541 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:14 pm |
N/A N/A |
Axogen Inc. | AXGN | Scopelianos Angelo Chief R&D Officer |
637 | $19.2 | 10,120 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:14 pm |
N/A N/A |
Axogen Inc. | AXGN | Scopelianos Angelo Chief R&D Officer |
2,572 | $0 | 10,120 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:14 pm |
N/A N/A |
Axogen Inc. | AXGN | MARIANI PETER J EVP & Chief Financial Officer |
918 | $19.2 | 21,026 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:14 pm |
N/A N/A |
Axogen Inc. | AXGN | MARIANI PETER J EVP & Chief Financial Officer |
3,710 | $0 | 21,026 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:13 pm |
N/A N/A |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
728 | $19.2 | 13,360 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:13 pm |
N/A N/A |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
2,572 | $0 | 13,360 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:13 pm |
N/A N/A |
Axogen Inc. | AXGN | MARTINEZ MARIA D. Chief Human Resources Officer |
637 | $19.2 | 4,867 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:13 pm |
N/A N/A |
Axogen Inc. | AXGN | MARTINEZ MARIA D. Chief Human Resources Officer |
2,572 | $0 | 4,867 (Direct) |
View |
| 2021-07-20 Tax Withholding |
2021-07-21 4:12 pm |
N/A N/A |
Axogen Inc. | AXGN | Friedman Mark Louis VP Regulatory Affairs & Policy |
637 | $19.2 | 16,308 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:12 pm |
N/A N/A |
Axogen Inc. | AXGN | Friedman Mark Louis VP Regulatory Affairs & Policy |
2,572 | $0 | 16,308 (Direct) |
View |
| 2021-07-19 Option Award |
2021-07-21 4:10 pm |
N/A 2031-07-19 |
Axogen Inc. | AXGN | JOHNSON JOHN Director |
27,638 | $0 | 27,638 (Direct) |
View |
| 2021-06-17 Exercise |
2021-06-21 4:17 pm |
N/A N/A |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
9,250 | $19.17 | 355,775 (Direct) |
View |
| 2021-06-17 Exercise |
2021-06-21 4:17 pm |
N/A 2028-12-27 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
9,250 | $0 | 355,775 (Direct) |
View |
| 2021-06-17 Tax Withholding |
2021-06-21 4:17 pm |
N/A N/A |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
8,781 | $20.92 | 355,775 (Direct) |
View |
| 2021-06-04 Exercise |
2021-06-08 4:25 pm |
N/A 2021-12-29 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
24,000 | $3.67 | 355,306 (Direct) |
View |
| 2021-05-19 Exercise(A) |
2021-06-07 5:25 pm |
N/A 2022-08-26 |
Axogen Inc. | AXGN | NEELS GUIDO J Director |
25,000 | $3.8 | 42,591 (Direct) |
View |
| 2021-05-19 Exercise(A) |
2021-06-07 5:25 pm |
N/A 2022-12-29 |
Axogen Inc. | AXGN | NEELS GUIDO J Director |
15,000 | $5.09 | 42,591 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:15 pm |
N/A 2031-06-01 |
Axogen Inc. | AXGN | Gold Mark Stephen Director |
9,066 | $0 | 311,505 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 5:15 pm |
N/A N/A |
Axogen Inc. | AXGN | Gold Mark Stephen Director |
6,173 | $0 | 311,505 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:14 pm |
N/A 2031-06-01 |
Axogen Inc. | AXGN | THOMAS PAUL Director |
9,066 | $0 | 9,066 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:14 pm |
N/A 2031-06-01 |
Axogen Inc. | AXGN | Wendell Amy McBride Director |
9,066 | $0 | 41,163 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 5:14 pm |
N/A N/A |
Axogen Inc. | AXGN | Wendell Amy McBride Director |
6,173 | $0 | 41,163 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:13 pm |
N/A 2031-06-01 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
9,066 | $0 | 9,066 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:13 pm |
N/A 2031-06-01 |
Axogen Inc. | AXGN | Blackford Quentin S. Director |
9,066 | $0 | 33,365 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 5:13 pm |
N/A N/A |
Axogen Inc. | AXGN | Blackford Quentin S. Director |
6,173 | $0 | 33,365 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:12 pm |
N/A 2031-06-01 |
Axogen Inc. | AXGN | NEELS GUIDO J Director |
9,066 | $0 | 57,830 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 5:12 pm |
N/A N/A |
Axogen Inc. | AXGN | NEELS GUIDO J Director |
6,173 | $0 | 57,830 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-03 5:11 pm |
N/A 2031-06-01 |
Axogen Inc. | AXGN | Levine Alan M Director |
9,066 | $0 | 17,830 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-03 5:11 pm |
N/A N/A |
Axogen Inc. | AXGN | Levine Alan M Director |
6,173 | $0 | 17,830 (Direct) |
View |
| 2021-05-26 Exercise |
2021-05-28 4:05 pm |
N/A 2022-12-29 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
9,000 | $5.09 | 331,306 (Direct) |
View |
| 2021-05-26 Exercise |
2021-05-28 4:05 pm |
N/A 2021-12-29 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
22,954 | $3.67 | 331,306 (Direct) |
View |
| 2021-05-26 Exercise |
2021-05-28 4:05 pm |
N/A 2023-05-26 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
21,000 | $5.45 | 331,306 (Direct) |
View |
| 2021-05-26 Exercise |
2021-05-28 4:05 pm |
N/A 2026-12-29 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
50,000 | $8.95 | 331,306 (Direct) |
View |
| 2021-05-19 Exercise |
2021-05-21 4:21 pm |
N/A 2022-08-26 |
Axogen Inc. | AXGN | NEELS GUIDO J Director |
25,000 | $3.8 | 42,591 (Direct) |
View |
| 2021-05-19 Exercise |
2021-05-21 4:21 pm |
N/A 2022-12-29 |
Axogen Inc. | AXGN | NEELS GUIDO J Director |
15,000 | $5.09 | 42,591 (Direct) |
View |
| 2021-04-28 Exercise |
2021-04-30 4:10 pm |
2015-05-01 2021-05-01 |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP of Clin. & Trans. Sciences |
10,000 | $2.86 | 78,082 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-20 4:09 pm |
N/A 2022-12-29 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
100,000 | $5.09 | 875,912 (Direct) |
View |
| 2021-03-25 Exercise |
2021-03-29 4:17 pm |
2015-12-29 2021-12-29 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
69,000 | $3.67 | 665,912 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 5:56 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | Friedman Mark Louis VP Regulatory Affairs & Policy |
35,300 | $0 | 35,300 (Direct) |
View |